Intravenous System Access Devices

Intravenous System Access Devices Market Outlook

The global Intravenous System Access Devices market is projected to reach USD 8.2 billion by 2035, growing at a compound annual growth rate (CAGR) of 6.1% from 2025 to 2035. The growth of this market is primarily fueled by the rising incidence of chronic diseases, an increasing volume of surgical procedures requiring intravenous access, and advancements in technology that enhance the efficiency and safety of intravenous therapies. Additionally, the growing emphasis on patient-centric care and the rising demand for minimally invasive procedures are significant contributors to the market expansion. Furthermore, the increasing geriatric population, which is prone to chronic health conditions requiring continuous intravenous therapy, further propels market development.

Growth Factor of the Market

Several factors are driving the growth of the Intravenous System Access Devices market. One of the primary drivers is the surge in chronic diseases such as diabetes, cancer, and cardiovascular ailments, which necessitate frequent and prolonged intravenous access for medication administration and treatment. Additionally, technological innovations in intravenous delivery systems, including the development of smart catheters that minimize complications and improve patient outcomes, are contributing to market growth. Moreover, a rising number of outpatient surgeries and procedures that demand efficient intravenous access are further propelling demand. The increasing awareness regarding the benefits of early diagnosis and treatment is also contributing positively to the market. Lastly, the growth of home healthcare services has augmented the need for portable intravenous systems, providing a significant boost to this sector.

Key Highlights of the Market

• The market is projected to reach USD 8.2 billion by 2035.
• CAGR of 6.1% from 2025 to 2035.
• Rising incidence of chronic diseases and surgical procedures.
• Technological advancements improving safety and efficiency.
• Growing preference for minimally invasive procedures.

By Product Type

Peripheral Catheters:

Peripheral catheters are widely utilized for short-term intravenous access, typically inserted into the superficial veins of the extremities. Their ease of insertion and removal, along with a lower risk of complications, make them a preferred choice in both hospital and outpatient settings. Moreover, advancements in materials and design have significantly improved the comfort and safety profile of peripheral catheters, reducing the incidence of complications such as phlebitis and infiltration. The increasing demand for these devices in outpatient care settings, where shorter hospital stays are common, is expected to drive growth in this segment. As healthcare continues to evolve towards more outpatient-focused models, the role of peripheral catheters is poised to expand further.

Central Catheters:

Central catheters are designed for long-term intravenous access, typically inserted into large veins such as the subclavian or jugular vein. These devices are essential for patients requiring extended therapy, such as those undergoing chemotherapy or requiring total parenteral nutrition. The central catheters are equipped with features that minimize the risk of infection, a critical concern for healthcare providers. The rising prevalence of cancer and the corresponding increase in chemotherapy treatments are primary drivers for the growth of this market segment. Additionally, ongoing research and development efforts aimed at enhancing the safety and efficacy of central catheters are further contributing to market growth.

Midline Catheters:

Midline catheters are inserted into veins that are at a distance from the heart, offering a balance between short-term and long-term access. They are particularly suitable for patients requiring intravenous therapy for weeks but do not need the prolonged access that central catheters provide. The midline catheters have gained popularity due to their lower complication rates compared to central venous catheters, particularly in terms of infection and thrombosis. As more healthcare providers recognize the benefits of midline catheters for various treatments, the demand for this product type is expected to grow significantly.

Peripherally Inserted Central Catheters:

Peripherally Inserted Central Catheters (PICC) are a vital option for patients requiring long-term intravenous therapy, especially in settings where traditional central lines are not preferable. These devices can be placed using ultrasound guidance, reducing the risk of complications and enhancing placement success rates. The rising number of chronic diseases and the need for long-term IV therapy, particularly in outpatient settings, is driving the demand for PICCs. Furthermore, increasing awareness among healthcare professionals regarding the benefits of PICCs over traditional IV methods is expected to contribute positively to market growth.

Implantable Ports:

Implantable ports are another critical segment in the intravenous access devices market, offering an effective solution for patients needing long-term access to the venous system. These ports are surgically implanted beneath the skin, reducing the risk of infection and allowing for repeated access without the need for frequent venipunctures. The growing prevalence of conditions requiring long-term intravenous therapies, such as cancer and chronic illnesses, is propelling the market for implantable ports. Their increasing adoption in outpatient and home healthcare settings further enhances their market potential. The advancements in design and materials also contribute to a growing preference for implantable ports due to their safety and patient comfort.

By Application

Medication Administration:

Medication administration is one of the primary applications of intravenous access devices, enabling healthcare providers to deliver drugs directly into the bloodstream. The efficiency of this method ensures fast therapeutic effects, making it critical for acute and chronic disease management. As the healthcare landscape shifts towards more outpatient services, the demand for reliable and efficient medication administration systems continues to rise. The increasing complexity of medication regimens, especially for patients with comorbid conditions, further emphasizes the importance of advanced intravenous systems. Additionally, the growing trend of home healthcare services drives the need for portable and user-friendly intravenous devices, fostering market expansion.

Blood Transfusion:

The use of intravenous access devices for blood transfusion is crucial in emergency and surgical settings, where rapid blood volume restoration can be life-saving. With the rising incidence of trauma cases and surgical procedures, the demand for efficient blood transfusion systems is experiencing significant growth. Healthcare providers are increasingly adopting advanced intravenous devices that ensure swift and safe blood delivery, minimizing the risk of transfusion-related complications. Additionally, growing awareness regarding blood donation and transfusion safety is further enhancing the market for intravenous devices used in this application, promoting safer practices and potentially increasing blood product utilization.

Parenteral Nutrition:

Parenteral nutrition is a critical application for intravenous access devices, particularly for patients unable to meet their nutritional needs through oral or enteral routes. This method is essential for patients with gastrointestinal disorders, severe malnutrition, or undergoing extensive surgical procedures. The increasing prevalence of conditions necessitating parenteral nutrition is driving the demand for safe and effective intravenous devices. Additionally, advancements in the formulation of parenteral nutrition solutions and the growing emphasis on personalized nutrition are further propelling this market segment. As healthcare continues to recognize the importance of nutritional support, the role of intravenous access devices in this application will remain significant.

Chemotherapy:

Chemotherapy is another vital application of intravenous access devices, particularly for cancer patients who require frequent treatments over extended periods. The use of central venous access devices facilitates the administration of chemotherapeutic agents while minimizing complications such as phlebitis and extravasation. As the global cancer burden continues to rise, the demand for reliable intravenous devices tailored to chemotherapy applications is expected to grow. Furthermore, the increasing development of targeted therapies and immunotherapies, which often require complex dosing regimens, underscores the need for advanced intravenous systems that can accommodate these requirements safely and efficiently.

Others:

This category includes various applications of intravenous access devices, such as hydration, electrolyte management, and emergency medication delivery. The versatile nature of intravenous devices allows for their use in numerous clinical scenarios, particularly in emergency care settings where rapid access to the vascular system is crucial. The ongoing need for efficient intravenous solutions across various medical disciplines, including emergency medicine, pediatrics, and critical care, continues to sustain market growth in this segment. As healthcare practices evolve, the demand for multifunctional intravenous access devices capable of meeting diverse clinical needs is anticipated to rise, driving the overall market.

By Distribution Channel

Hospitals:

Hospitals are the primary distribution channel for intravenous access devices, accounting for a significant share of the market. The extensive use of these devices in various departments, including emergency, surgical, and oncology, underscores their importance in patient care. As hospitals continue to adapt to the growing patient population and increasing demands for advanced medical treatments, the need for reliable intravenous systems is expected to rise correspondingly. Furthermore, the integration of technology in hospitals, such as electronic health records and real-time monitoring systems, is enhancing the efficiency of intravenous therapy administration, promoting further market growth.

Clinics:

Clinics play a vital role in the distribution of intravenous access devices, particularly in outpatient settings. The increasing shift towards outpatient care, driven by advancements in medical technology and a focus on cost-effective healthcare solutions, is significantly boosting the demand for intravenous devices in clinics. These facilities often handle a wide range of procedures that require intravenous access, including minor surgeries and chronic disease management. The growing number of private clinics and specialized outpatient facilities is expected to contribute to the expansion of this distribution channel, particularly as patient preferences shift towards receiving care in less acute settings.

Ambulatory Surgical Centers:

Ambulatory surgical centers (ASCs) are increasingly becoming prominent distribution channels for intravenous access devices, especially due to the growing trend of outpatient surgeries. These centers provide a wide range of surgical and procedural services while eliminating the need for hospital admission, making them an attractive option for patients. The efficiency and safety of intravenous access systems in ASCs are critical for ensuring positive patient outcomes. As more surgical procedures are performed in ASCs, the demand for advanced intravenous devices tailored for these environments is anticipated to grow, aligning with the broader trend of outpatient care.

Homecare Settings:

Homecare settings represent a burgeoning distribution channel for intravenous access devices, driven by the increasing adoption of home healthcare services. Patients requiring long-term intravenous therapy, such as those with chronic diseases or undergoing palliative care, benefit significantly from the convenience and comfort of receiving treatment at home. The growing emphasis on patient-centric care, coupled with advances in portable intravenous technologies, is facilitating the expansion of this market segment. As healthcare systems worldwide continue to transition towards home-based care models, the demand for effective and safe intravenous access devices for home use is expected to rise substantially, presenting significant opportunities for manufacturers.

Others:

This category encompasses various distribution channels beyond hospitals and clinics, including rehabilitation centers, long-term care facilities, and emergency medical services. The demand for intravenous access devices in these settings is driven by the diverse patient populations requiring intravenous therapy for a myriad of conditions. As healthcare providers increasingly recognize the importance of efficient intravenous access in delivering timely and effective care, the utilization of these devices in non-traditional settings is expected to grow. The evolution of healthcare delivery models towards more integrated and patient-focused care will further support the expansion of this distribution channel.

By Material Type

Polyurethane:

Polyurethane is a widely used material in the manufacturing of intravenous access devices, known for its biocompatibility and flexibility. This material's favorable mechanical properties enable comfortable insertion and prolonged use, making it ideal for various intravenous devices, including catheters and ports. Polyurethane's resistance to kinking and its ability to maintain lumen patency under pressure further enhance its utility in clinical applications. The increasing adoption of polyurethane-based devices is expected to drive the market as healthcare providers prioritize patient comfort and safety in intravenous therapy.

Silicone:

Silicone is another prominent material used in intravenous access devices, particularly for applications requiring biocompatibility and resistance to chemical degradation. The smooth surface of silicone devices reduces friction during insertion, minimizing patient discomfort. Moreover, silicone's excellent flexibility and adaptability make it suitable for various intravenous applications, including long-term catheters and implantable ports. As the demand for biocompatible materials continues to rise, the market for silicone-based intravenous devices is projected to expand significantly, driven by their advantages in safety and effectiveness.

Polyethylene:

Polyethylene is utilized in the production of intravenous access devices, particularly in the context of lower-cost alternatives. While not as commonly used as polyurethane or silicone, polyethylene serves as a reliable option for short-term IV access devices. Its lightweight and flexible nature make it suitable for various applications, although it may not offer the same level of durability or biocompatibility as other materials. The demand for polyethylene-based devices is expected to persist, particularly in cost-sensitive markets, as healthcare providers seek affordable alternatives for intravenous therapy.

Others:

This category includes various materials used in the manufacturing of intravenous access devices, such as PVC and composite materials. The development of new materials and composites designed to enhance the performance and safety of intravenous devices is a key trend in this segment. As manufacturers continue to innovate and create advanced materials that provide improved mechanical properties, biocompatibility, and resistance to infection, the demand for these devices is likely to increase. Furthermore, the growing focus on environmentally-friendly materials and sustainable practices in healthcare is expected to influence the development and adoption of alternative materials for intravenous access devices.

By Region

The geographical analysis of the Intravenous System Access Devices market highlights significant growth in North America, which is projected to account for approximately 40% of the global market by 2035. This dominance is attributed to the advanced healthcare infrastructure, high prevalence of chronic diseases, and significant investments in healthcare innovation. The increasing adoption of outpatient and home-based care models, along with a growing aging population requiring ongoing medical care, further drives the demand for intravenous devices in this region. Additionally, collaborations between healthcare providers and manufacturers to develop advanced intravenous technologies are expected to contribute to market growth in North America.

Europe holds a substantial share of the Intravenous System Access Devices market, accounting for nearly 30% of the total revenue by 2035. The growth in this region is driven by factors such as an aging population, rising healthcare expenditures, and increasing awareness regarding the benefits of intravenous therapies. The market in Europe is expected to grow at a CAGR of 5.5% from 2025 to 2035, aided by advancements in healthcare technology and an emphasis on improving patient care outcomes. The presence of major players in the region, coupled with stringent regulatory frameworks promoting safety and efficacy in intravenous therapy, will further bolster market growth across European countries.

Opportunities

The Intravenous System Access Devices market presents numerous opportunities for growth and innovation. One significant opportunity lies in the increasing demand for home healthcare solutions, driven by a growing elderly population and a rising prevalence of chronic diseases that require long-term intravenous therapy. As healthcare systems shift towards patient-centric models, the need for portable and user-friendly intravenous devices designed for home use is becoming paramount. Manufacturers can capitalize on this trend by developing advanced intravenous systems that integrate telehealth capabilities, allowing healthcare providers to monitor patients remotely and ensure safety and efficacy in treatment. Additionally, the expansion of home healthcare services is expected to create a burgeoning market for intravenous access devices specifically tailored for home settings.

Another substantial opportunity exists in the realm of technological advancements within the intravenous access devices sector. The ongoing development of smart intravenous systems equipped with sensors and real-time monitoring capabilities presents significant prospects for enhancing patient safety and treatment outcomes. These innovative solutions can provide healthcare professionals with valuable data regarding infusion rates, potential complications, and patient adherence to therapy regimens. As the healthcare industry increasingly embraces digital health technologies, manufacturers who invest in the research and development of smart intravenous devices are likely to gain a competitive edge in the market. Furthermore, partnerships between technology companies and healthcare providers can accelerate the adoption of these cutting-edge solutions, ultimately driving market growth.

Threats

Despite the promising outlook for the Intravenous System Access Devices market, several threats could hinder its growth. One of the most significant concerns is the increasing occurrence of infections associated with intravenous access, which can lead to serious complications and increased healthcare costs. The rising incidence of catheter-related bloodstream infections poses a substantial challenge for healthcare providers, prompting a need for stricter infection control protocols and the development of safer intravenous devices. The growing awareness of these risks may lead to reduced utilization of traditional intravenous access systems, thus impacting market growth. Additionally, the emergence of alternative drug delivery methods, such as subcutaneous and intramuscular routes, may further threaten the demand for intravenous access devices as healthcare providers seek to minimize complications.

Another potential restraining factor for the market is the regulatory landscape surrounding the approval and commercialization of intravenous access devices. Stringent regulations and lengthy approval processes can impede the timely introduction of innovative products into the market. Manufacturers may face challenges in navigating the complex regulatory environment, leading to delays in product launches and increased costs associated with compliance. Furthermore, as competition intensifies within the intravenous access devices market, companies must continually invest in research and development to stay ahead. This continual investment may strain smaller organizations and limit their ability to compete effectively against larger, more established players with greater resources.

Competitor Outlook

• BD (Becton, Dickinson and Company)
• Smiths Medical
• Medtronic
• Cardinal Health
• Vygon S.A.
• Teleflex Incorporated
• Fresenius Kabi AG
• Boston Scientific Corporation
• Terumo Corporation
• Cook Medical
• AngioDynamics Inc.
• Halyard Health
• Eitan Medical
• IVANNEX
• B. Braun Melsungen AG

The competitive landscape of the Intravenous System Access Devices market is characterized by the presence of several key players that dominate various segments, highlighting the dynamic nature of this industry. Major companies, such as BD (Becton, Dickinson and Company) and Medtronic, leverage their extensive product portfolios and strong distribution networks to capture significant market shares. These industry leaders are continually investing in research and development to introduce innovative products that enhance patient safety and treatment efficacy. Moreover, strategic collaborations and partnerships with healthcare providers and technology firms enable these companies to expand their reach and improve their competitive position in the market.

Another notable player, Smiths Medical, is recognized for its commitment to quality and patient-centric design in its intravenous access devices. The company emphasizes innovation by integrating advanced technologies into its product lines to address the evolving needs of healthcare providers. Similarly, Teleflex Incorporated has established itself as a key player in the market, focusing on the development of specialized intravenous access devices that improve patient outcomes while minimizing complications. The ongoing trend of mergers and acquisitions within the industry also highlights the strategic moves companies are making to enhance their market presence and diversify their product offerings.

Fresenius Kabi AG and Vygon S.A. are also prominent competitors in the Intravenous System Access Devices market, known for their wide range of intravenous products designed to meet diverse clinical requirements. These companies emphasize research and innovation to maintain their competitive edge, frequently introducing new products that address unmet needs in the market. Furthermore, the increasing focus on patient safety and infection prevention has prompted companies to develop more advanced intravenous devices, contributing to a shift in market dynamics. The competitive landscape is expected to continue evolving as companies adapt to changing healthcare trends and prioritize the development of safe, effective, and user-friendly intravenous access devices.

• 1 Appendix

  • 1.1 List of Tables
  • 1.2 List of Figures

• 2 Introduction

  • 2.1 Market Definition
  • 2.2 Scope of the Report
  • 2.3 Study Assumptions
  • 2.4 Base Currency & Forecast Periods

• 3 Market Dynamics

  • 3.1 Market Growth Factors
  • 3.2 Economic & Global Events
  • 3.3 Innovation Trends
  • 3.4 Supply Chain Analysis

• 4 Consumer Behavior

  • 4.1 Market Trends
  • 4.2 Pricing Analysis
  • 4.3 Buyer Insights

• 5 Key Player Profiles

  • 5.1 IVANNEX
    • 5.1.1 Business Overview
    • 5.1.2 Products & Services
    • 5.1.3 Financials
    • 5.1.4 Recent Developments
    • 5.1.5 SWOT Analysis
  • 5.2 Medtronic
    • 5.2.1 Business Overview
    • 5.2.2 Products & Services
    • 5.2.3 Financials
    • 5.2.4 Recent Developments
    • 5.2.5 SWOT Analysis
  • 5.3 Vygon S.A.
    • 5.3.1 Business Overview
    • 5.3.2 Products & Services
    • 5.3.3 Financials
    • 5.3.4 Recent Developments
    • 5.3.5 SWOT Analysis
  • 5.4 Cook Medical
    • 5.4.1 Business Overview
    • 5.4.2 Products & Services
    • 5.4.3 Financials
    • 5.4.4 Recent Developments
    • 5.4.5 SWOT Analysis
  • 5.5 Eitan Medical
    • 5.5.1 Business Overview
    • 5.5.2 Products & Services
    • 5.5.3 Financials
    • 5.5.4 Recent Developments
    • 5.5.5 SWOT Analysis
  • 5.6 Halyard Health
    • 5.6.1 Business Overview
    • 5.6.2 Products & Services
    • 5.6.3 Financials
    • 5.6.4 Recent Developments
    • 5.6.5 SWOT Analysis
  • 5.7 Smiths Medical
    • 5.7.1 Business Overview
    • 5.7.2 Products & Services
    • 5.7.3 Financials
    • 5.7.4 Recent Developments
    • 5.7.5 SWOT Analysis
  • 5.8 Cardinal Health
    • 5.8.1 Business Overview
    • 5.8.2 Products & Services
    • 5.8.3 Financials
    • 5.8.4 Recent Developments
    • 5.8.5 SWOT Analysis
  • 5.9 Fresenius Kabi AG
    • 5.9.1 Business Overview
    • 5.9.2 Products & Services
    • 5.9.3 Financials
    • 5.9.4 Recent Developments
    • 5.9.5 SWOT Analysis
  • 5.10 AngioDynamics Inc.
    • 5.10.1 Business Overview
    • 5.10.2 Products & Services
    • 5.10.3 Financials
    • 5.10.4 Recent Developments
    • 5.10.5 SWOT Analysis
  • 5.11 Terumo Corporation
    • 5.11.1 Business Overview
    • 5.11.2 Products & Services
    • 5.11.3 Financials
    • 5.11.4 Recent Developments
    • 5.11.5 SWOT Analysis
  • 5.12 B. Braun Melsungen AG
    • 5.12.1 Business Overview
    • 5.12.2 Products & Services
    • 5.12.3 Financials
    • 5.12.4 Recent Developments
    • 5.12.5 SWOT Analysis
  • 5.13 Teleflex Incorporated
    • 5.13.1 Business Overview
    • 5.13.2 Products & Services
    • 5.13.3 Financials
    • 5.13.4 Recent Developments
    • 5.13.5 SWOT Analysis
  • 5.14 Boston Scientific Corporation
    • 5.14.1 Business Overview
    • 5.14.2 Products & Services
    • 5.14.3 Financials
    • 5.14.4 Recent Developments
    • 5.14.5 SWOT Analysis
  • 5.15 BD (Becton, Dickinson and Company)
    • 5.15.1 Business Overview
    • 5.15.2 Products & Services
    • 5.15.3 Financials
    • 5.15.4 Recent Developments
    • 5.15.5 SWOT Analysis

• 6 Market Segmentation

  • 6.1 Intravenous System Access Devices Market, By Application
    • 6.1.1 Medication Administration
    • 6.1.2 Blood Transfusion
    • 6.1.3 Parenteral Nutrition
    • 6.1.4 Chemotherapy
    • 6.1.5 Others
  • 6.2 Intravenous System Access Devices Market, By Product Type
    • 6.2.1 Peripheral Catheters
    • 6.2.2 Central Catheters
    • 6.2.3 Midline Catheters
    • 6.2.4 Peripherally Inserted Central Catheters
    • 6.2.5 Implantable Ports
  • 6.3 Intravenous System Access Devices Market, By Material Type
    • 6.3.1 Polyurethane
    • 6.3.2 Silicone
    • 6.3.3 Polyethylene
    • 6.3.4 Others
  • 6.4 Intravenous System Access Devices Market, By Distribution Channel
    • 6.4.1 Hospitals
    • 6.4.2 Clinics
    • 6.4.3 Ambulatory Surgical Centers
    • 6.4.4 Homecare Settings
    • 6.4.5 Others

• 7 Competitive Analysis

  • 7.1 Key Player Comparison
  • 7.2 Market Share Analysis
  • 7.3 Investment Trends
  • 7.4 SWOT Analysis

• 8 Research Methodology

  • 8.1 Analysis Design
  • 8.2 Research Phases
  • 8.3 Study Timeline

• 9 Future Market Outlook

  • 9.1 Growth Forecast
  • 9.2 Market Evolution

• 10 Geographical Overview

  • 10.1 Europe - Market Analysis
    • 10.1.1 By Country
      • 10.1.1.1 UK
      • 10.1.1.2 France
      • 10.1.1.3 Germany
      • 10.1.1.4 Spain
      • 10.1.1.5 Italy
  • 10.2 Asia Pacific - Market Analysis
    • 10.2.1 By Country
      • 10.2.1.1 India
      • 10.2.1.2 China
      • 10.2.1.3 Japan
      • 10.2.1.4 South Korea
  • 10.3 Latin America - Market Analysis
    • 10.3.1 By Country
      • 10.3.1.1 Brazil
      • 10.3.1.2 Argentina
      • 10.3.1.3 Mexico
  • 10.4 North America - Market Analysis
    • 10.4.1 By Country
      • 10.4.1.1 USA
      • 10.4.1.2 Canada
  • 10.5 Middle East & Africa - Market Analysis
    • 10.5.1 By Country
      • 10.5.1.1 Middle East
      • 10.5.1.2 Africa
  • 10.6 Intravenous System Access Devices Market by Region

• 11 Global Economic Factors

  • 11.1 Inflation Impact
  • 11.2 Trade Policies

• 12 Technology & Innovation

  • 12.1 Emerging Technologies
  • 12.2 AI & Digital Trends
  • 12.3 Patent Research

• 13 Investment & Market Growth

  • 13.1 Funding Trends
  • 13.2 Future Market Projections

• 14 Market Overview & Key Insights

  • 14.1 Executive Summary
  • 14.2 Key Trends
  • 14.3 Market Challenges
  • 14.4 Regulatory Landscape

Segments Analyzed in the Report

The global Intravenous System Access Devices market is categorized based on

By Product Type

• Peripheral Catheters
• Central Catheters
• Midline Catheters
• Peripherally Inserted Central Catheters
• Implantable Ports

By Application

• Medication Administration
• Blood Transfusion
• Parenteral Nutrition
• Chemotherapy
• Others

By Distribution Channel

• Hospitals
• Clinics
• Ambulatory Surgical Centers
• Homecare Settings
• Others

By Material Type

• Polyurethane
• Silicone
• Polyethylene
• Others

By Region

• North America
• Europe
• Asia Pacific
• Latin America
• Middle East & Africa

Key Players

• BD (Becton, Dickinson and Company)
• Smiths Medical
• Medtronic
• Cardinal Health
• Vygon S.A.
• Teleflex Incorporated
• Fresenius Kabi AG
• Boston Scientific Corporation
• Terumo Corporation
• Cook Medical
• AngioDynamics Inc.
• Halyard Health
• Eitan Medical
• IVANNEX
• B. Braun Melsungen AG